Furthermore, the expression levels of CYP1A1, NOCT, and TUBB6 were regulated, indicating the effects of improving the antioxidant capacity of liver tissues, reducing the steatosis of hepatocytes, and inhibiting the inflammatory reaction of hepatocytes, respectively. The gene discussed is NOCT; the disease is steatosis.